[Kuru-type sclerosing panencephalomyelitis in Europe].
D001479:Basal Ganglia / Q000473:pathology; D001933:Brain Stem / Q000473:pathology; D002531:Cerebellum / Q000473:pathology; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D002675:Child, Preschool; D003937:Diagnosis, Differential; D004200:Diseases in Twins; D004569:Electroencephalography; D004679:Encephalomyelitis / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D005260:Female; D006236:Handwriting; D006801:Humans; D007729:Kuru / Q000175:diagnosis*; D008297:Male; D008578:Meninges / Q000473:pathology; D001523:Mental Disorders / Q000150:complications; D009069:Movement Disorders / Q000150:complications; D009410:Nerve Degeneration; D009778:Occipital Lobe / Q000473:pathology; D009847:Olivary Nucleus / Q000473:pathology; D011055:Poliovirus Vaccine, Oral / Q000009:adverse effects; D011689:Purkinje Cells; D012897:Slow Virus Diseases / Q000139:chemically induced / Q000150:complications; D013116:Spinal Cord / Q000473:pathology
D002556:Cerebrospinal Fluid Proteins; D011055:Poliovirus Vaccine, Oral
Kuruähnliche sklerosierende Panencephalomyelitis in Europa.